News

The latest in medical toxicology

Stay informed with the latest in medical toxicology. Explore news on research, poisoning outbreaks, global trends, and new treatments. Our news section covers everything from environmental toxins to regulatory updates, keeping you ahead in this field.

Public Health Warnings and Recalls

FDA Finds Sildenafil, Acetaminophen in 10 Day Forecast

21 Oct 2026

FDA lab testing graphic shows 10 Day Forecast with undeclared sildenafil and acetaminophen, highlighting nitrate-interaction and cumulative exposure risks.

Public Health Warnings and Recalls

FDA Posts Recall of 22 Argatroban Lots Over Particles

17 Oct 2026

Hospital pharmacy graphic shows 22 Argatroban Injection lots recalled after cellulose, plastics, stopper material and possible stainless steel particles were detected.

Public Health Warnings and Recalls

Babies' Magic Tea Recalled After FDA Finds Three Alcohols

17 Oct 2026

Lab-tested Babies' Magic Tea lot 25122bw shown with undeclared ethanol, methanol and isopropanol levels and a voluntary recall notice for caregivers.

Public Health Warnings and Recalls

RAPTURE Preworkout Recalled After FDA Finds Hidden DMAA

09 Oct 2026

Lab testing graphic shows RAPTURE Preworkout lot 260327-4 recalled nationwide after undeclared 1,3-DMAA was detected, with cardiovascular risk highlighted.

Regulatory and Policy Updates

FDA Reviews OTC Imidazoline Misuse Toxicity Signals

07 Oct 2026 · Updated 09 Oct 2026

Medical toxicology graphic showing OTC imidazoline products, misuse and wrong-route exposure, and FDA AEMS cardiovascular and cerebrovascular safety signals.

Substance Abuse and Overdose

Cychlorphine Emerges in the Illicit Opioid Supply as Toxicology Testing Finds Unrecognized Exposure

07 Oct 2026 · Updated 09 Oct 2026

Cychlorphine toxicology image showing advanced drug analysis, Estonia study findings of 22 of 112 samples, and naloxone-responsive opioid toxicity.

Public Health Warnings and Recalls

TGA Posts Andrographis Product Recalls as Anaphylaxis Safety Action Escalates

05 Oct 2026 · Updated 31 Oct 2026

Australian pharmacy graphic showing an expanded October 23 TGA recall list for Andrographis medicines because of severe and unpredictable anaphylaxis risk.

Substance Abuse and Overdose

70 Suspected Overdoses in Waterloo Region Highlight Complex Fentanyl Mixtures

05 Oct 2026

Waterloo Region alert highlights 70 suspected drug poisonings and fentanyl mixtures containing medetomidine, benzodiazepines, para-fluorofentanyl and nitazenes.

Public Health Warnings and Recalls

FDA Adds Lior Ground Cinnamon to Lead Contamination Alert

03 Oct 2026

Lior Ground Cinnamon lot GAP11304 shown with Maryland testing, a 2.18 ppm lead finding, six-state distribution, and product-recall warning.

Public Health Warnings and Recalls

FDA Classifies Superpotent Thyroid Tablet Recall as Class I

03 Oct 2026

Vitruvias Thyroid Tablets USP 30 mg lot 504950 shown with T4/T3 excess and cardiac-risk cues to illustrate FDA’s Class I superpotency recall.

Showing 11–20 of 237